Type 2 diabetes: Synjardy ® (empagliflozin/metformin hydrochloride) approved in the European Union

Type 2 diabetes: Synjardy ® (empagliflozin/metformin hydrochloride) approved in the European Union

https://www.boehringer-ingelheim.com/press-release/type-2-diabetes-synjardy-empa...

Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

More News: Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Fortamet | Jardiance | Metformin | Research